These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2495638)

  • 1. Effects of gamma interferon and interleukin-2, and of gamma-interferon antibodies, on the rat immune response against allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Jacques Y; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):999-1001. PubMed ID: 2495638
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Schellekens H; Jacques Y; Soulillou JP
    J Heart Lung Transplant; 1991; 10(3):424-30. PubMed ID: 1906747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
    Kupiec-Weglinski JW; van der Meide P; Stunkel KG; Tanaka K; Diamantstein T; Tilney NL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):992-3. PubMed ID: 2495637
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat.
    Didlake RH; Kim EK; Sheehan K; Schreiber RD; Kahan BD
    Transplantation; 1988 Jan; 45(1):222-3. PubMed ID: 3122384
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased IFN-gamma and IL-2 mRNA expression in peripheral tolerance to heart allografts with conserved granzyme A, perforin, and MHC antigens mRNA expression.
    Bugeon L; Cuturi MC; Paineau J; Chabannes D; Soulillou JP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):314-6. PubMed ID: 8438315
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T; Sayegh MH; Kut JP; Hancock WW; Milford EL; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin 2 receptor in rat allograft rejection.
    Bouchot O; Anegon I; Romaniuk A; Jacques Y; Soulillou JP
    Transplant Proc; 1990 Aug; 22(4):1995-7. PubMed ID: 2202134
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Sablinski T; Hancock WW; Mix CT; Tilney NL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):285-6. PubMed ID: 1990533
    [No Abstract]   [Full Text] [Related]  

  • 9. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Kupiec-Weglinski JW; Hancock WW; Stunkel K; Diamantstein T; Tilney NL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-interferon-like substance is expressed in myocytes of cardiac allografted rats treated with cyclosporine A.
    Wanders A; Wells AF; Tufveson G; Klareskog L
    Transplant Proc; 1992 Feb; 24(1):346. PubMed ID: 1539309
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of the immune response by interferon gamma administration in a rat cardiac allograft model.
    Bouwman E; IJzermans JN; vd Meide PH; Schellekens H; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):465-6. PubMed ID: 2495612
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of interferon alpha/beta on cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
    Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
    Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
    [No Abstract]   [Full Text] [Related]  

  • 16. Rat cardiac allografts protected with cyclosporin A are rejected in the presence of LS-2616 (Linomide).
    Gerdin B; Wanders A; Tufveson G
    Transplant Proc; 1989 Feb; 21(1 Pt 1):853-5. PubMed ID: 2650284
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts.
    Ito T; Stepkowski SM; Shirakura R; Nakata S; Yamamoto S; Nozaki S; Miyata M; Matsuda H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):885-7. PubMed ID: 8442257
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
    Tanaka K; Turka LA; Ueda H; Diamantstein T; Milford EL; Carpenter CB; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):475-6. PubMed ID: 2523145
    [No Abstract]   [Full Text] [Related]  

  • 19. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immune response in rejection and tolerance of rat liver allografts.
    Sun J; Rokahr K; Nakagawa H; McCaughan GW; Sheil AG; Bishop GA
    Transplant Proc; 1995 Jun; 27(3):2159-60. PubMed ID: 7792918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.